These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 21785319)
21. Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs. Marmor M; Titus S; Wolfe H; Krasinski K; Maslansky R; Simberkoff M; Beatrice S; Nichols S; Des Jarlais DC AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S207-13. PubMed ID: 7865302 [TBL] [Abstract][Full Text] [Related]
22. HIV prevalence among injection drug users in rural Guangxi China. Liu W; Chen J; Rodolph M; Beauchamp G; Mâsse B; Wang S; Li R; Ruan Y; Zhou F; Leung MK; Lai S; Shao Y; Jackson JB Addiction; 2006 Oct; 101(10):1493-8. PubMed ID: 16968351 [TBL] [Abstract][Full Text] [Related]
23. Background demographics and risk behaviors of injecting drug users in Karachi, Pakistan. Parviz S; Fatmi Z; Altaf A; McCormick JB; Fischer-Hoch S; Rahbar M; Luby S Int J Infect Dis; 2006 Sep; 10(5):364-71. PubMed ID: 16793307 [TBL] [Abstract][Full Text] [Related]
24. Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Strathdee SA; Patrick DM; Archibald CP; Ofner M; Cornelisse PG; Rekart M; Schechter MT; O'Shaughnessy MV Addiction; 1997 Oct; 92(10):1339-47. PubMed ID: 9489050 [TBL] [Abstract][Full Text] [Related]
25. HIV infection among injecting drug users in north-east Malaysia, 1992. Singh S; Crofts N AIDS Care; 1993; 5(3):273-81. PubMed ID: 8218462 [TBL] [Abstract][Full Text] [Related]
26. Continuing HIV transmission among injection drug users in Eastern Central Canada: the SurvUDI Study, 1995 to 2000. Hankins C; Alary M; Parent R; Blanchette C; Claessens C; J Acquir Immune Defic Syndr; 2002 Aug; 30(5):514-21. PubMed ID: 12154342 [TBL] [Abstract][Full Text] [Related]
27. HIV incidence and associated risk factors among female sex workers in a high HIV-prevalence area of China. Wang H; Reilly KH; Brown K; Jin X; Xu J; Ding G; Zang C; Wang J; Wang N Sex Transm Dis; 2012 Nov; 39(11):835-41. PubMed ID: 23064531 [TBL] [Abstract][Full Text] [Related]
28. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. Craib KJ; Spittal PM; Wood E; Laliberte N; Hogg RS; Li K; Heath K; Tyndall MW; O'Shaughnessy MV; Schechter MT CMAJ; 2003 Jan; 168(1):19-24. PubMed ID: 12515780 [TBL] [Abstract][Full Text] [Related]
29. Trends in the incidence of HIV in Scotland, 1988-2009. McDonald SA; Hutchinson SJ; Wallace LA; Cameron SO; Templeton K; McIntyre P; Molyneaux P; Weir A; Codere G; Goldberg DJ Sex Transm Infect; 2012 Apr; 88(3):194-9. PubMed ID: 22158935 [TBL] [Abstract][Full Text] [Related]
30. Seroconversion issues among out-of-treatment injection drug users. Fisher DG; Fenaughty AM; Trubatch B J Psychoactive Drugs; 1998; 30(3):299-305. PubMed ID: 9798796 [TBL] [Abstract][Full Text] [Related]
31. Cessation of injecting drug use among street-based youth. Steensma C; Boivin JF; Blais L; Roy E J Urban Health; 2005 Dec; 82(4):622-37. PubMed ID: 16195471 [TBL] [Abstract][Full Text] [Related]
32. HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. Moss AR; Vranizan K; Gorter R; Bacchetti P; Watters J; Osmond D AIDS; 1994 Feb; 8(2):223-31. PubMed ID: 8043227 [TBL] [Abstract][Full Text] [Related]
33. High HIV incidence in a cohort of male injection drug users in Delhi, India. Sarna A; Saraswati LR; Sebastian M; Sharma V; Madan I; Lewis D; Pulerwitz J; Thior I; Tun W Drug Alcohol Depend; 2014 Jun; 139():106-14. PubMed ID: 24768060 [TBL] [Abstract][Full Text] [Related]
34. Risk indicators associated with injection drug use in the Aboriginal population. Lemstra M; Rogers M; Thompson A; Moraros J; Buckingham R AIDS Care; 2012; 24(11):1416-24. PubMed ID: 22292863 [TBL] [Abstract][Full Text] [Related]
35. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. Nelson KE; Galai N; Safaeian M; Strathdee SA; Celentano DD; Vlahov D Am J Epidemiol; 2002 Oct; 156(7):641-53. PubMed ID: 12244033 [TBL] [Abstract][Full Text] [Related]
36. Sex Work as an Emerging Risk Factor for Human Immunodeficiency Virus Seroconversion Among People who Inject Drugs in the SurvUDI Network. Blouin K; Leclerc P; Morissette C; Roy É; Blanchette C; Parent R; Serhir B; Alary M Sex Transm Dis; 2016 Oct; 43(10):648-55. PubMed ID: 27631361 [TBL] [Abstract][Full Text] [Related]
37. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Kral AH; Bluthenthal RN; Lorvick J; Gee L; Bacchetti P; Edlin BR Lancet; 2001 May; 357(9266):1397-401. PubMed ID: 11356437 [TBL] [Abstract][Full Text] [Related]
38. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. Patrick DM; Strathdee SA; Archibald CP; Ofner M; Craib KJ; Cornelisse PG; Schechter MT; Rekart ML; O'Shaughnessy MV Int J STD AIDS; 1997 Jul; 8(7):437-45. PubMed ID: 9228591 [TBL] [Abstract][Full Text] [Related]
39. Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, Maryland, U.S.A. Vlahov D; Khabbaz RF; Cohn S; Galai N; Taylor E; Kaplan JE J Acquir Immune Defic Syndr Hum Retrovirol; 1995 May; 9(1):89-96. PubMed ID: 7712239 [TBL] [Abstract][Full Text] [Related]
40. Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: a 16-year longitudinal study. Bruneau J; Daniel M; Abrahamowicz M; Zang G; Lamothe F; Vincelette J Am J Epidemiol; 2011 May; 173(9):1049-58. PubMed ID: 21362739 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]